Title Participants "MGMT PROMOTER STATUS IN IDH1/2 MUTANT ANAPLASTIC ASTROCYTOMA PATIENTS ASSESSED BY DNA METHYLATION PROFILING AND QMS-PCR: A REPORT FROM THE EORTC BRAIN TUMOR GROUP" "Paul Clement" "PROGNOSTIC SIGNIFICANCE OF EPIGENETIC SUBTYPES AND CPGS ASSOCIATED WITH PROGRESSION TO G-CIMP LOW IN THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON" "C Mircea S Tesileanu, Martin van den Bent, Thais Sabedot, Marc Sanson, Alba Brandes, Wolfgang Wick, Paul Clement, Sarah Erridge, Michael Vogelbaum, Anna Nowak, Jean Baurain, Warren Mason, Helen Wheeler, Michael Weller, Iris de Heer, Hendrikus Dubbink, Johan M Kros, Kenneth Aldape, Pieter Wesseling, Vassilis Golfinopoulos, Thierry Gorlia, Brigitta Baumert, Houtan Noushmehr, Pim French" "IDH1/2WT ANAPLASTIC GLIOMAS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL: OVERALL SURVIVAL RELATED TO TREATMENT, MGMT STATUS AND MOLECULAR FEATURES OF GLIOBLASTOMA" "C Mircea S Tesileanu, Pim French, Sarah Erridge, Michael Vogelbaum, Anna Nowak, Marc Sanson, Alba Brandes, Wolfgang Wick, Paul Clement, Jean Baurain, Warren Mason, Helen Wheeler, Michael Weller, Kenneth Aldape, Pieter Wesseling, Johan M Kros, Vassilis Golfinopoulos, Thierry Gorlia, Brigitta Baumert, Martin van den Bent" "CAPMATINIB (INC280) IN MET Delta EX14-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): EFFICACY DATA FROM THE PHASE 2 GEOMETRY MONO-1 STUDY" "Rebecca S Heist, Takashi Seto, Ji-Youn Han, Noemi Reguart, Edward B Garon, Harry JM Groen, Daniel SW Tan, Toyoaki Hida, Maja de Jonge, Sergey V Orlov, Egbert F Smit, Pierre-Jean Souquet, Johan Vansteenkiste, Sylvie Le Mouhaer, Anna Robeva, Maeve Waldron-Lynch, Monica Giovannini, Juergen Wolf" "IDENTIFICATION OF P53 PRIONS AS AN INDEPENDENT PROGNOSTIC MARKER FOR SURVIVAL IN HIGH-GRADE SEROUS OVARIAN CANCER" "Nicole Heinzl, Elisabeth Maritschnegg, Katarzyna Koziel, Stuart Wilson, Georg Heinze, Christine Wallisch, Reinhard Horvat, Jalid Sehouli, Ioana Braicu, Ignace Vergote, Els Van Nieuwenhuysen, Sven Mahner, Eva Obermayr, Eva Schuster, Barbara Holzer, Nicole Concin, Robert Zeillinger" "INFIGRATINIB (BGJ398) IN PATIENTS WITH RECURRENT GLIOMAS WITH FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR) ALTERATIONS: A MULTICENTER PHASE II STUDY" "Andrew Lassman, Juan Sepulveda-Sanchez, Timothy Cloughesy, Juan Gil-Gil, Vinay Puduvalli, Jeffrey Raizer, Filip De Vos, Patrick Wen, Nicholas Butowski, Paul Clement, Morris Groves, Cristobal Belda-Iniesta, Keith Steward, Steven Rowsey, Yining Ye, Patrick Roth" "A PATIENT-DERIVED CANCER CELL LINE ATLAS OF PRIMARY AND METASTATIC CENTRAL NERVOUS SYSTEM TUMORS" "Frederik De Smet, Yuen-Yi Tseng, Shakti Ramkissoon, Lori Ramkissoon, Kristine Pelton, Ruben Ferrer Luna, Dena Panovska, Kate Schoolcraft, Fiona Watkinson, Shawna Bilton, Victoria Hung, Kin-Hoe Chow, Jack Geduldig, Sarah Becker, Robert Jones, Paula Keskula, Sahar Alkhairy, Mimoun Delmar, Josh Arraya, Crystal Oh, Alexa Yeagley, Anneke Kramm, E Antonio Chiocca, Wenya Linda Bi, Mark Kieran, Brian Alexander, Ian Dunn, Rameen Beroukhim, Jesse Boehm, Keith Ligon" "TWO-YEAR RESULTS OF THE INTELLANCE 2/EORTC TRIAL 1410 RANDOMIZED PHASE II STUDY ON DEPATUX-M ALONE, DEPATUX-M COMBINED WITH TEMOZOLOMIDE (TMZ) AND EITHER TMZ OR LOMUSTINE IN RECURRENT EGFR AMPLIFIED GLIOBLASTOMA (NCT02343406" "Martin van den Bent, Pim French, Marica Eoli, Juan Sepulveda, Annemiek Walenkamp, Jean-Sebastian Frenel, Enrico Franceschi, Paul Clement, Michael Weller, Iris de Heer, Jim Looman, Jyotirmoy Dey, Scott Krause, Hao Xiong, Peter Ansell, Sarah Nuyens, Joana Brilhante, Maarten Spruyt, Thierry Gorlia, Vassilis Golfinopoulos" "PATIENTS WITH EGFR AMPLIFICATION BUT WITHOUT EGFRvIII EXPRESSION HAVE IMPROVED BENEFIT COMPARED TO THOSE WITH EGFRvIII EXPRESSION IN SAMPLES OF THE INTELLANCE 2/EORTC 1410 RANDOMIZED PHASE II TRIAL" "Pim French, Johan Kros, Iris de Heer, Marica Eoli, Juan Sepulveda, Annemiek Walenkamp, Jean-Sebastien Frenel, Enrico Franceschi, Paul Clement, Michael Weller, Peter Ansell, Jim Looman, Earle Bain, Marie Morfouace, Thierry Gorlia, Vassilis Golfinopoulos, Martin van den Bent" "NEUROCOGNITIVE OUTCOMES OF EORTC BRAIN TUMOR GROUP STUDY 26101 PHASE III TRIAL COMPARING THE COMBINATION OF LOMUSTINE AND BEVACIZUMAB WITH LOMUSTINE ALONE IN GLIOBLASTOMA PATIENTS WITH FIRST PROGRESSION" "Martin Klein, Jaap C Reijneveld, Ahmed Idbaih, Alba Brandes, Walter Taal, Paul Clement, Julien Domont, Mario Campone, Martin JB Taphoorn, Roger Stupp, Michel Fabbro, Emilie Le Rhun, Francois Dubois, Michael Weller, Vassilis Golfinopoulos, Michael Platten, Thierry Gorlia, Martin van den Bent, Wolfgang Wick"